Qualitative study investigating the underlying motivations of healthy participants in phase I clinical trials

OBJECTIVES: If patients are to reap the benefits of continued drug development, an understanding of why healthy participants take part in phase I clinical trials is imperative. The current study aimed to explore the nature of these underlying motivations which may, in turn, improve the overall parti...

Descripción completa

Detalles Bibliográficos
Autores principales: Manton, Kerry J, Gauld, Cassandra S, White, Katherine M, Griffin, Paul M, Elliott, Suzanne L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340482/
https://www.ncbi.nlm.nih.gov/pubmed/30647042
http://dx.doi.org/10.1136/bmjopen-2018-024224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340482/
https://www.ncbi.nlm.nih.gov/pubmed/30647042
http://dx.doi.org/10.1136/bmjopen-2018-024224

Ejemplares similares